S116836 is a tyrosine kinase inhibitor. It synergistically induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells. References: Shen Y, Ren X, Ding K, Zhang Z, Wang D, Pan J. Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells. Oncotarget. 2014 Nov 15;5(21):10407-20. PubMed PMID: 25431951; PubMed Central PMCID: PMC4279382.

纯度：≥98%

CAS：1257628-57-1